RALEIGH, N.C., June 25, 2025 /PRNewswire/ -- Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Dehydrated Alcohol Injection to its line of cardiovascular drugs. Accord's product is AB-rated to BPI Labs' Ablysinol® and is offered in 99% 5mL vials. Dehydrated...
Hence then, the article about accord healthcare launches dehydrated alcohol injection for cardiovascular indications was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Accord Healthcare Launches Dehydrated Alcohol Injection for Cardiovascular Indications )
Also on site :
- ‘The Comeback’ took on Hollywood long before ‘The Studio.’ Now, Valerie Cherish will have her curtain call
- FLRT Energy Drinks Launch in 4 ‘Groovy’ Flavors After Last-Minute Rebrand
- ‘Project Hail Mary’ Answers Prayers: Best Opening For MPA Movie YTD With Near $141M WW — Global B.O. Update
